# Absco Therapeutics, Inc. — Form D

Absco Therapeutics, Inc. of ALLSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-27. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-08-27
- Form: D
- Accession: 0002023557-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2025-08-18
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-556003

## Issuer

- Name: Absco Therapeutics, Inc.
- CIK: 0002023557
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 127 WESTERN AVENUE, ALLSTON, MA, 02134
- Phone: 314-917-7620

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Linderman | Director | Allston, MA |
| Avik Som | Director | Allston, MA |
| Carlo Giovanni Traverso | Director | Allston, MA |
| Stephen Linderman | Executive Officer | Allston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-05-28](https://search.stillhousedata.com/formd/0002023557-24-000001) | D | $2.0M | $2.0M |

## More

- [CIK 2023557 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2023557&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002023557-25-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.